Hints and tips:
...All assets may perform badly under stagflation, but we’d rather own Pepsi, Johnson & Johnson, Kimberly-Clark, Bristol-Myers et al than sit and watch our cash lose its earnings power....
...According to SEC filings, Elon Musk’s company is the $60bn hedge fund’s second largest holding, behind Bristol-Myers Squibb....
...The sale allows Bristol-Myers Squibb to push ahead with its mammoth $90bn takeover of Celgene....
...The two banks have landed on some of the biggest deals of the year, with JPMorgan advising on the $90bn tie-up between Bristol-Myers Squibb and Celgene and Goldman providing advice to Allergan on its $85bn...
International Edition